A COALITION of researchers from Monash University, the University of Melbourne and The Indian Institute of Chemical Biology has been awarded A$1m research funding to develop new treatments for the disease leishmaniasis.
The sand-fly spread systemic blood disease is endemic in 88 countries across five continents.
Researchers hope to progress an advanced candidate drug to formal preclinical development by 2021.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Apr 17